Background
==========

Conventional methods such as linear regression and logistic regression are widely used in genetic association tests in the presence of gene-gene or gene-environment interaction. In recent years several new methods have been developed. Based on Tukey\'s non-additivity model, Chatterjee et al. \[[@B1]\] proposed a model that makes use of \"generalized association parameters\" to map additional genes while allowing for gene-gene and gene-environment interactions. This method may have higher power to detect genetic variants than some existing methods. One drawback of their work is that it does not accommodate the situation in which the main effect of the second gene is bounded by constant times its interaction effect with the first gene. To overcome this drawback, Wang \[[@B2]\] proposed a method and derived the asymptotic distribution of the likelihood-ratio test statistic. This method allows the main effect of the second gene to be bounded but does not assume it to be zero. However, the method proposed by Wang is for a continuous phenotype. In this report, we generalized that method to case-control study so it can be applied to the Genetic Analysis Workshop 16 (GAW16) Problem 1 data.

We choose to study genes *HLA-DRB1*using its shared-epitope alleles and *KCNB1*. The relationship between *HLA-DRB1*and increased risk for rheumatoid arthritis has been studied for 20 years, and several high risk alleles of *HLA-DRB1*are treated as shared-epitope alleles \[[@B3],[@B4]\], which are used widely in association study for rheumatoid arthritis \[[@B5]\]. There are also some studies covering regions including genes *PTPN22*and *TRAF-C5*, and at least two alleles of *PTPN22*were associated with increased risk for rheumatoid arthritis \[[@B6]\]. In a genome-wide study, *TRAF-C5*was found to be a risk locus for rheumatoid arthritis \[[@B7]\]. Unlike *PTPN22*and *TRAF-C5*, which are supported by statistical evidence, there is some functional evidence supporting the active role of *KCNB1*in rheumatoid arthritis. The functional channel in human T lymphocytes is composed of four identical *KCNB1*sub-units, and several peptide inhibitor of *KCNB1*have been developed as therapy for autoimmune diseases \[[@B8]\] such as type 1 diabetes mellitus and rheumatoid arthritis. An expression study \[[@B9]\] found that there is a downregulation of potassium channels including *KCNB1*in autoimmune diseases.

Because the association signal of *KCNB1*is not very strong (it has not been discovered by other genome-wide association studies), we conjecture that its effect may mainly be manifested through its interaction with the *HLA-DRB1*gene. The goal of the current analysis is to investigate whether the gene *KCNB1*, a previously reported gene associated with rheumatoid arthritis, is associated with rheumatoid arthritis in this GAW16 dataset. For this purpose, we use two statistical techniques, including one particularly developed for this study, which may be helpful in mapping genes that have weak main effect.

Methods
=======

The GAW16 Problem 1 data comes from the North American Rheumatoid Arthritis Consortium (NARAC) and includes 868 cases and 1194 controls. Single-nucleotide polymorphisms (SNPs) of all individuals were genotyped using 550 k Illumina chip (*n*= 545,080). A genome-wide association scan based on the trend test was performed to assess the association of all SNPs to rheumatoid arthritis.

The regular logistic regression of two-locus disease model with interaction is logit(*π*(*x*)\|*SE*, *SNP*) = *α*~0~+ *α*~1~× *SE*+ *α*~2~× *SNP*+ *α*~3~× *SE*× *SNP*, where SE is the number of shared-epitope alleles of *HLA-DRB1*and SNP is the number of a chosen allele at an SNP of *KCNB1*, and the coefficients *α*~2~and *α*~3~measure the additional contribution of locus 2 over that of locus 1. A traditional test of both effects with two degrees of freedom is used to assess the association of the second locus, and the hypotheses to be tested are *H*~0~: *α*~2~= *α*~3~= 0 vs. *H*~1~: *α*~2~≠ 0 or *α*~3~≠ 0. This test treats the coefficients *α*~2~and *α*~3~as unrelated to each other because one of two coefficients can be 0 regardless of the values of the other one. However, this test may not be effective because the values of *α*~2~and *α*~3~could depend on whether there is association due to locus 2.

The situation of interest in this study is that main effect \|*α*~2~\|, is constrained by the interaction \|*α*~3~\| effect. The constraint is *α*~3~≠ 0, \|*α*~2~\| ≤ *M*× \|*α*~3~\|, with *M*a pre-specified constant, and then the hypotheses to test in this study are *H*~0~: *α*~2~= *α*~3~= 0 vs. *H*~1~: *α*~3~≠ 0, \|*α*~2~\| ≤ *M*× \|*α*~3~\|. Based on this constraint, two extreme situations need to be considered. When *M*is set to be 0, *α*~2~has to be 0 as well, and then the test measures interaction effect only (H~1~: *α*~2~= 0, *α*~3~≠ 0) with 1 df; when *M*is very large, *α*~2~is not affected by *α*~3~, and then the test measures both effects (*H*~1~: *α*~2~≠ 0 or *α*~3~≠ 0) with 2 df.

An appropriate value for *M*should achieve a balance between measuring interaction only and both effects. Based on some simulation results in linear regression \[[@B2]\], when *M*is in the range of \[0.1, 0.3\], the asymptotic quantiles of statistic based on this test seem to be rather different from those of the interaction-only test and the both-effects test. We set *M*to 0.4 in this analysis because the value of *M*should reflect the moderate association of *KCNB1*and it should not be too small. Because the distribution of the likelihood-ratio statistic of this proposed test is unknown for case-control study, and in order to compare *p*-values, the estimation of the *p*-values need to be based on the same procedure. Ten thousand permutations are used to estimate the *p*-values in three tests for each SNP.

We also use principal-component analysis to test multiple SNPs in *KCNB1*jointly. The principal components were obtained via the statistical package R (version 2.6.2) based on the correlation coefficient matrix.

Results
=======

The result of a genome-wide association scan is consistent with previous studies \[[@B8]\], with the strongest signal coming from HLA region on 6p21. For genes *HLA-DRB1*and *KCNB1*, a *p*-value \< 10^-100^for *HLA-DRB1*and the range of *p*-values for *KCNB1*from 10^-4^to 10^-7^were set as thresholds for significance.

*KCNB1*(potassium voltage-gated channel, Shab-related subfamily; member 1) is 110,667 bp long; mRNA is 3756 bp long and encodes a protein of 858 amino acids. Position information comes from *Homo sapiens*chromosome 20 genomic contig, NT_011362.9. There are 36 SNPs available in *KCNB1*for this dataset, rs1051295 (A/G) is located in 3\'UTR and all others are located in introns. The most significant 15 SNPs from this gene in the initial scan were selected in subsequent analysis. The first principal component accounts for about 80% of variation for 15 SNPs. The proposed method was applied to these 15 SNPs and the first component (Table [1](#T1){ref-type="table"}). Also presented in Table [1](#T1){ref-type="table"} are two tests: interaction effect only test (*H*~1~: *α*~2~= 0, *α*~3~≠ 0), and both effects test (*H*~1~: *α*~2~≠ 0 or *α*~3~≠ 0). In Table [1](#T1){ref-type="table"}, *p*-values show that the interaction-effect-only test and the proposed test are more significant than the both-effects test, and the overall strengths of these two tests are similar. *p*-Values of six SNPs based on the proposed test are smaller than those of interaction-only test; *p*-values of four SNPs based on interaction-only test are smaller than those of the proposed test; *p*-values of two SNPs are the same. Because of limitation of the number of permutations, *p*-values of three SNPs and the first principal component cannot be compared (*p*-value \< 0.0001).

###### 

*p*-Values in three association tests based on 10,000 permutations

  SNP                         ID          Position     function   Interaction effect   Both effects   Proposed model
  --------------------------- ----------- ------------ ---------- -------------------- -------------- ----------------
  1                           rsl051295   47,422,312   3\'UTR     0.0008               0.0018         0.0008
  2                           rs2426154   47,435,402   intron     0.0011               0.0017         0.0008
  3                           rs237485    47,437,645   intron     0.0008               0.0015         0.0008
  4                           rs1961192   47,439,714   intron     0.0004               0.0005         0.0003
  5                           rs9636516   47,440,607   intron     0.0007               0.0017         0.0012
  6                           rs6063397   47,449,616   intron     0.0011               0.0023         0.0008
  7                           rs2057077   47,457,043   intron     0.0011               0.0017         0.0005
  8                           rs6067085   47,458,509   intron     0.0001               0.0011         0.0004
  9                           rs6090975   47,459,969   intron     \<0.0001             \<0.0001       \<0.0001
  10                          rs6125647   47,460,870   intron     0.0003               0.0004         \<0.0001
  11                          rs926673    47,463,417   intron     \<0.0001             \<0.0001       \<0.0001
  12                          rs237462    47,466,610   intron     0.0019               0.0035         0.0021
  13                          rs237476    47,484,789   intron     0.0052               0.0102         0.0076
  14                          rs742758    47,495,219   intron     \<0.0001             \<0.0001       \<0.0001
  15                          rs572845    47,510,021   intron     0.0027               0.0022         0.0007
  First principal component                                       \<0.0001             \<0.0001       \<0.0001

Discussion
==========

The association between *HLA-DRB1*gene and rheumatoid arthritis is very strong. Except for some known genes, a genome-wide scan found no other genes that show obvious association. One possibility is that other genes have a weak main effect, making them hard to detect. We propose a method for case-control study that allows the main effect of the second gene to be weak relative to its interaction effect with the first gene. Using this model, we studied the association between *KCNB1*and rheumatoid arthritis.

The results of three tests used in this study support our assumption that the effect of *KCNB1*may mainly be manifested through its interaction with the *HLA-DRB1*gene.

The interaction-effect only test (*M*= 0) and the proposed test (*M*= 0.4) perform better than the both-effects test; for six SNPs, the proposed test even performs better than interaction-effect-only test.

The *M*value reflects the strength of main effect in the proposed model. *M*values of 0.1 and 0.4 represent small effect and moderate effect, respectively. Considering the moderate main effect of *KCNB1*, we set *M*value to be 0.4. The *M*value should be determined by researchers, every gene has different *M*value. A wrongly chosen *M*value will reduce the power in the test, so we suggest that a rough range of *M*values should be determined by some prior information, and then a number of interations be used to get the appropriate *M*value. Computing burden is a big concern in case-control study. When the number of permutations is larger than 10,000, comparisons cannot be made, so a more efficient algorithm for permutation needs to be developed. This method is more applicable in linear regression because the asymptotic distribution of the likelihood-ratio test statistic has been derived \[[@B2]\].

Previous studies have reported association of rheumatoid arthritis to *KCNB1*gene. Based on our analysis, the association strength between *KCNB1*and rheumatoid arthritis seems to be moderate in the GAW16 Problem 1 data.

Conclusion
==========

We used two methods, including one developed by us, to investigate the association between *KCNB1*gene and rheumatoid arthritis. Based on results, the strength of the association is moderate. This association needs further confirmation.
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